Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venkatadri Kolla

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Cancer Research|January 15, 2014
Role of CHD5 in human cancers: 10 years laterVenkatadri Kolla, Tiangang Zhuang, Mayumi Higashi, et al.
Expert Opinion on Therapeutic Targets|January 7, 2014
Therapeutic targets for neuroblastomasGarrett M Brodeur, Radhika Iyer, Jamie L Croucher, et al.
Molecular Cancer|August 7, 2015
Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastomaMayumi Higashi, Venkatadri Kolla, Radhika Iyer, et al.
Mechanisms of Development|November 21, 2013
CHD5 is required for spermiogenesis and chromatin condensationTiangang Zhuang, Rex A Hess, Venkatadri Kolla, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 6, 2007
Developmental regulation of DUOX1 expression and function in human fetal lung epithelial cellsHorst Fischer, Linda K Gonzales, Venkatadri Kolla, et al.
The Biochemical Journal|April 1, 2015
The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complexVenkatadri Kolla, Koumudi Naraparaju, Tiangang Zhuang, et al.
Drug Design, Development and Therapy|January 8, 2020
A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft ModelIsabella Orienti, Ferro Nguyen, Peng Guan, et al.
American Journal of Respiratory Cell and Molecular Biology|September 9, 2006
Thyroid transcription factor in differentiating type II cells: regulation, isoforms, and target genesVenkatadri Kolla, Linda W Gonzales, John Gonzales, et al.
International Journal of Nanomedicine|September 28, 2020
Nanomicellar Lenalidomide-Fenretinide Combination Suppresses Tumor Growth in an <i>MYCN</i> Amplified Neuroblastoma TumorIsabella Orienti, Giovanna Farruggia, Ferro Nguyen, et al.
Molecular Cancer Therapeutics|December 25, 2019
Mechanisms of Entrectinib Resistance in a Neuroblastoma Xenograft ModelSuzanne P MacFarland, Koumudi Naraparaju, Radhika Iyer, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cancer Research|January 15, 2014
Role of CHD5 in human cancers: 10 years laterVenkatadri Kolla, Tiangang Zhuang, Mayumi Higashi, et al.
Expert Opinion on Therapeutic Targets|January 7, 2014
Therapeutic targets for neuroblastomasGarrett M Brodeur, Radhika Iyer, Jamie L Croucher, et al.
Molecular Cancer|August 7, 2015
Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastomaMayumi Higashi, Venkatadri Kolla, Radhika Iyer, et al.
Mechanisms of Development|November 21, 2013
CHD5 is required for spermiogenesis and chromatin condensationTiangang Zhuang, Rex A Hess, Venkatadri Kolla, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 6, 2007
Developmental regulation of DUOX1 expression and function in human fetal lung epithelial cellsHorst Fischer, Linda K Gonzales, Venkatadri Kolla, et al.
The Biochemical Journal|April 1, 2015
The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complexVenkatadri Kolla, Koumudi Naraparaju, Tiangang Zhuang, et al.
Drug Design, Development and Therapy|January 8, 2020
A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft ModelIsabella Orienti, Ferro Nguyen, Peng Guan, et al.
American Journal of Respiratory Cell and Molecular Biology|September 9, 2006
Thyroid transcription factor in differentiating type II cells: regulation, isoforms, and target genesVenkatadri Kolla, Linda W Gonzales, John Gonzales, et al.
International Journal of Nanomedicine|September 28, 2020
Nanomicellar Lenalidomide-Fenretinide Combination Suppresses Tumor Growth in an <i>MYCN</i> Amplified Neuroblastoma TumorIsabella Orienti, Giovanna Farruggia, Ferro Nguyen, et al.
Molecular Cancer Therapeutics|December 25, 2019
Mechanisms of Entrectinib Resistance in a Neuroblastoma Xenograft ModelSuzanne P MacFarland, Koumudi Naraparaju, Radhika Iyer, et al.
Pageof 3